Potent Antitumor Effects of a Combination of Three Nutraceutical Compounds

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• Head and neck squamous cell carcinoma (HNSCC) presents a significant therapeutic challenge due to low survival rates and high morbidity associated with current treatments.
• Nutraceuticals, derived from dietary sources, offer a potential alternative with fewer side effects but often exhibit limited antitumor efficacy as single agents.

Purpose of the Study:

• To investigate the synergistic potential of combining nutraceuticals for enhanced efficacy in HNSCC treatment.
• To delineate the mechanism of action of a novel nutraceutical combination, GZ17-6.02, against HNSCC.

Main Methods:

• Three nutraceutical formulations (GZ17-S, GZ17-05.00, GZ17-6.02) were evaluated for their effects on HNSCC proliferation, migration, invasion, angiogenesis, and apoptosis in vitro.
• The most effective formulation, GZ17-6.02, was further assessed in combination with cisplatin and tested in vivo using HNSCC cell lines, patient-derived xenografts, and murine models.

Main Results:

• GZ17-6.02, comprising curcumin, harmine, and isovanillin, demonstrated significant inhibition of HNSCC progression in vitro.
• The combination of GZ17-6.02 with cisplatin enhanced anti-proliferative effects.
• In vivo studies showed significant inhibition of tumor growth by GZ17-6.02 in various models (P < 0.001).
• Molecular analysis revealed inhibition of key signaling pathways including EGFR, ERK1/2, and AKT.

Conclusions:

• GZ17-6.02 is a highly effective nutraceutical combination with potent anti-cancer activity against HNSCC.
• The study validates the synergistic potential of combining specific plant-derived compounds for cancer therapy.
• GZ17-6.02 shows promise for future clinical applications in HNSCC treatment.